Neoadjuvant ceritinib treatment in ALK ‐rearranged locally advanced adenosquamous carcinoma: A case report

Here, we first report a case of neoadjuvant ceritinib for locally advanced lung adenosquamous carcinoma. In this study, a locally advanced adenosquamous carcinoma (ASC) patient with EML4‐ALK fusion who achieved a partial response with neoadjuvant ceritinib treatment after a cycle of neoadjuvant chem...

Descripción completa

Detalles Bibliográficos
Autores principales: Mai, Shixiong, Wang, Yue, Wang, Xuemei, Yang, Wei, Gao, Haicheng, Xu, Zhenan, Xu, Lei, Xu, Li, Ou, Qiuxiang, Chen, Hanlin, Wang, Zhenxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346166/
https://www.ncbi.nlm.nih.gov/pubmed/35818908
http://dx.doi.org/10.1111/1759-7714.14558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346166/
https://www.ncbi.nlm.nih.gov/pubmed/35818908
http://dx.doi.org/10.1111/1759-7714.14558

Ejemplares similares